Last reviewed · How we verify
Sulide (NIMESULIDE)
At a glance
| Generic name | NIMESULIDE |
|---|---|
| Drug class | nimesulide |
| Target | Myeloperoxidase, Aromatase, Interstitial collagenase |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer (PHASE2)
- First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors (PHASE1)
- The Effect of Different Intra-articular Injections Primary Gonarthrosis (NA)
- Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID
- Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. (PHASE2)
- Postural Analysis During Dental Surgery (NA)
- Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients (PHASE3)
- LLLT of Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |